Building a strategic patent portfolio is crucial to success for a medtech startup. David J. Dykeman, Greenberg Traurig When it comes to starting and building a medical device company, a strong patent strategy tied to business goals can be the driving force behind venture capital investment, strategic collaborations, and mergers and acquisitions. In order to […]
Greenberg Traurig
Expect high acquisitions, possible bidding wars in 2018, medtech expert says
Look for another strong year for medtech acquisitions in 2018 — and even potential bidding wars — predicts patent attorney David Dykeman. The wave of mergers and acquisitions in the medical device industry should continue this year, both in terms of value and volume, according to patent attorney David Dykeman. “Many large medtech companies are […]
DeviceTalks West: Expertise you need to know
Medical device suppliers are light years away from the days when they merely filled orders to spec for medtech OEMs – as a visit to the upcoming DeviceTalks West will quickly confirm. From incorporating steerability into catheters to getting validation and testing done right, the companies serving the medical device industry have become specialized experts in […]
Why you should care about intellectual property
What do early stage companies really need to focus on? Patent attorney David Dykeman says, first and foremost, that it’s intellectual property protection. Dykeman –who co-chairs Greenberg Traurig’s global Life Sciences & Medical Technology Group – will speak at DeviceTalks Boston on October 2. We asked him to give us some ideas on the important issues surrounding […]
MassDevice Q&A: Greenberg Traurig’s Lori Cohen on defending product liability lawsuits
When it comes to defending product liability lawsuits, it’s tough to top Greenberg Traurig’s Lori Cohen and her 98.3% winning percentage – she’s 57-for-58 lifetime in the courtroom.* Cohen, a shareholder at the law firm, is chairwoman of GT’s pharmaceutical, medical device & healthcare litigation practice and its trial practice group. Based in Atlanta, she’s saved her medical […]
An M&A checklist for medical device companies
By David Dykeman and David Peck
Last year was a banner year for medtech investment and mergers & acquisitions, as companies busted out of the recession in style.
Matchmaking for medtech: Greenberg Traurig looks to bring companies together
Obamacare leaves autism coverage to states | MassDevice.com On Call
MASSDEVICE ON CALL — Advocate groups for autism, a disease which now affects 1 in 88 U.S. children, are disappointed with the Obama administration’s decision to leave autism coverage up to each state.
News makers and game changers at the MassDevice Big 100 East 2013
Nearly 300 of the industry’s best and brightest gathered for a night of big ideas, industry insights and few cocktails last night at MassDevice.com’s Big 100 East 2013 conference in Waltham, Mass.
Report: CMS Innovation Center’s 1st chief on the way out
Dr. Richard Gilfillan, the 1st leader of the recently-created Center for Medicare & Medicaid Services Innovation Center, will hand over the reigns at the end of the month, and no replacement has yet been named.
Edwards Lifesciences CFO Abate to retire | Personnel Moves
Edwards Lifesciences (NYSE:EW) said its finance chief, Thomas Abate, plans to retire later this year after a replacement is found.
The Irvine, Calif.-based medical device company said Abate, 60, will stay on as CFO while the search goes on. Edwards hired Peter Crist of Crist/Kolder Associates to assist in the quest, according to a press release.